Temple University Health System’s preparations for and treatment of patients amidst the coronavirus pandemic continue to be part of the media’s COVID-19 coverage.
- Tony S. Reed, MD, MBA, Executive Vice President and Chief Medical Officer of Temple University Health System, and Ebonee Miller-Williams, Licensed Clinical Social Worker at Temple’s Community Care Transitions Program, spoke with the Philadelphia Inquirer for a story about President Donald Trump’s experience with COVID-19 vs. that of the general population, as well as the social, racial, and economic inequities in American health care that it has brought to light.
- The New York Times and the New Yorker interviewed Sara Goldrick-Rab, PhD, Professor of Sociology and Medicine at Temple University and Founding Director of the Hope Center for College, Community and Justice at the Lewis Katz School of Medicine at Temple University, for articles about the economic challenges, including food and/or housing insecurity, that low-income college students are facing during the COVID-19 pandemic.
- Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of the Temple Lung Center, joined the Becker’s Healthcare podcast to discuss Temple’s management of the COVID-19 pandemic, the steps the health system is taking to welcome patients back safely, and new technology available at the Lung Center (such as the Ion endoluminal system with Philips cone-beam CT). Dr. Criner emphasized Temple’s collaboration with colleagues overseas, its multidisciplinary treatment team, and its dedication to clinical trials, among other topics.
- Thomas Fekete, MD, MACP, Thomas Durant Chair and Professor of Medicine and Professor of Microbiology and Immunology at the Lewis Katz School of Medicine at Temple University, provided perspective on herd immunity and COVID-19 in an interview with Philadelphia magazine.
- Dr. Reed will participate in a Health Care Connect Innovators meeting on October 28th, during which he will present a review of the COVID-19 pandemic to date, describe its regional impacts, and share the recent accomplishments of Temple University Health System.
- Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, Clinical Professor at the Temple University School of Pharmacy, Clinical Pharmacy Specialist in Infectious Diseases at Temple University Hospital, and Director of the Postgraduate Year Two Infectious Diseases Residency at the Temple University School of Pharmacy, addressed the development of a coronavirus vaccine for the October issue of Contagion Live. Dr. Gallagher is the editor-in-chief of the publication.